Evidence map›Paper›PMID 30380664›Full record

ReviewInternational journal of molecular sciences2018

Anisotropic Gold Nanoparticles in Biomedical Applications.

Claudia Kohout, Cristina Santi, Laura Polito

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Advancing brain immunotherapy through functional nanomaterials.Drug delivery and translational research · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Bacterial synthesis of anisotropic gold nanoparticles.Applied microbiology and biotechnology · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Pharmaceutics · 2023
    Review
  20. Gold Nanoparticles Contact with Cancer Cell: A Brief Update.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Claudia KohoutDepartment of Chemistry, University of Milan, via C. Golgi 19, 20131 Milan, Italy. claudia.kohout@unimi.it.
Cristina SantiDepartment of Chemistry, University of Milan, via C. Golgi 19, 20131 Milan, Italy. cristina.santi@unimi.it.ORCID 0000-0003-0040-258X
Laura PolitoISTM-CNR, Nanotechnology Lab., via G. Fantoli 16/15, 20138 Milan, Italy. laura.polito@istm.cnr.it.ORCID 0000-0002-7756-2365

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gold nanoparticles (AuNPs) play a crucial role in the development of nanomedicine, principally due to their unique photophysical properties and high biocompatibility. The possibility to tune and customize the localized surface plasmon resonance (LSPR) toward near-infrared region by modulating the AuNP shape is one of the reasons for the huge widespread use of AuNPs. The controlled synthesis of no-symmetrical nanoparticles, named anisotropic, is an exciting goal achieved by the scientific community which explains the exponential increase of the number of publications related to the synthesis and use of such type of AuNPs. Even with such steps forward and the AuNP translation in clinic being done, some key issues are still remain and they are related to a reliable and scalable production, a full characterization, and to the development of nanotoxicology studies on the long run. In this review we highlight the very recent advances on the synthesis of the main classes of anisotropic AuNPs (nanorods, nanourchins and nanocages) and their use in the biomedical fields, in terms of diagnosis and therapeutics.

Indexed as

AnimalsAnisotropyGoldHumansMetal NanoparticlesNanomedicineNanotechnologyGoldanisotropic AuNPsbiomedical applicationsgold nanoparticlessynthesis

Identifiers

PMID30380664
PMCPMC6274885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.